Performance of BMY Bristol-Myers Squibb Co.. | -27% in 12m
Compare BMY with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Bristol-Myers Squibb Co.. with its related Sector/Index XLV
Performance Duell BMY vs XLV
TimeFrame | BMY | XLV |
---|---|---|
1 Day | 1.30% | 0.38% |
1 Week | 1.35% | 0.03% |
1 Month | -4.44% | -4.69% |
3 Months | -1.22% | -0.01% |
6 Months | -11.3% | 8.95% |
12 Months | -27.0% | 5.44% |
YTD | -5.09% | 0.48% |
Rel. Perf. 1m | -0.08 | |
Rel. Perf. 3m | -0.66 | |
Rel. Perf. 6m | -2.07 | |
Rel. Perf. 12m | -3.75 |
Is Bristol-Myers Squibb Co.. a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Bristol-Myers Squibb Co.. (NYSE:BMY) is currently (April 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 7.19 and therefor a positive outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BMY as of April 2024 is 49.92. This means that BMY is currently undervalued and has a potential upside of +2.02% (Margin of Safety).
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BMY as of April 2024 is 49.92. This means that BMY is currently undervalued and has a potential upside of +2.02% (Margin of Safety).
Is BMY a buy, sell or hold?
- Strong Buy: 2
- Buy: 4
- Hold: 19
- Sell: 0
- Strong Sell: 1
Values above 0%: BMY is performing better - Values below 0%: BMY is underperforming
Compare BMY with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.42% | -0.46% | -28.29% | -48.24% |
US NASDAQ 100 | QQQ | 6.74% | 1.01% | -26.97% | -57.92% |
US Dow Jones Industrial 30 | DIA | 1.37% | -1.60% | -26.08% | -41.16% |
German DAX 40 | DBXD | 2.47% | -2.97% | -29.08% | -37.90% |
UK FTSE 100 | ISFU | 2.78% | -4.37% | -20.83% | -30.58% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.66% | -3.06% | -12.74% | -10.22% |
Hongkong Hang Seng | HSI | 4.38% | 4.09% | -1.01% | -0.61% |
Japan Nikkei 225 | EXX7 | 6.77% | 2.07% | -25.37% | -44.23% |
India NIFTY 50 | INDA | 2.01% | -6.81% | -27.13% | -56.13% |
Brasil Bovespa | EWZ | 3.04% | -0.26% | -17.09% | -44.40% |
BMY Bristol-Myers Squibb Co.. vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 3.64% | -2.95% | -30.32% | -64.89% |
Consumer Discretionary | XLY | 5.50% | 1.55% | -21.95% | -42.51% |
Consumer Staples | XLP | -0.09% | -2.72% | -23.23% | -27.97% |
Energy | XLE | 2.56% | -7.47% | -16.63% | -40.88% |
Financial | XLF | 0.55% | -2.76% | -35.90% | -49.86% |
Health Care | XLV | 1.32% | 0.25% | -20.29% | -32.39% |
Industrial | XLI | 3.33% | -2.44% | -33.17% | -48.21% |
Materials | XLB | 2.42% | -2.58% | -29.29% | -38.33% |
Real Estate | XLRE | 5.00% | 3.01% | -22.24% | -25.81% |
Technology | XLK | 7.62% | 2.72% | -27.24% | -57.02% |
Utilities | XLU | -0.57% | -7.01% | -24.90% | -24.42% |
Aerospace & Defense | XAR | 2.48% | -1.06% | -25.24% | -40.62% |
Biotech | XBI | 7.39% | 7.30% | -34.82% | -27.55% |
Homebuilder | XHB | 5.26% | 1.53% | -51.95% | -73.00% |
Retail | XRT | 2.34% | 1.90% | -31.64% | -42.58% |
Does Bristol-Myers Squibb Co.. outperform its market, is BMY a Sector Leader?
No, over the last 12 months Bristol-Myers Squibb Co.. (BMY) made -26.95%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 5.44%.
Over the last 3 months BMY made -1.22%, while XLV made -0.01%.
No, over the last 12 months Bristol-Myers Squibb Co.. (BMY) made -26.95%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 5.44%.
Over the last 3 months BMY made -1.22%, while XLV made -0.01%.
Period | BMY | XLV | S&P 500 |
---|---|---|---|
1 Month | -4.44% | -4.69% | -3.98% |
3 Months | -1.22% | -0.01% | 2.96% |
12 Months | -26.95% | 5.44% | 21.29% |